Inhibition of Proliferation and Induction of Apoptosis by Gamma‐ or Delta‐Tocotrienols in Human Colorectal Carcinoma Cells
BioMed Research International · 2025
DOI: 10.1155/bmri/4421336 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioMed Research International, 2025. Verfasst von Ali Qusay Khalid und 4 weiteren Autor:innen. Beteiligte Einrichtung: Food as Medicine Research Strength, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia, monash…. Hauptthemen laut MEDLINE: Apoptosis, Colorectal Neoplasms, Cell Proliferation, Chromans. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia.
Abstract (Originalsprache)
Colorectal cancer (CRC) remains a significant global health concern, necessitating the exploration of novel therapeutic approaches. This study investigated the anticancer effects of γ ‐tocotrienol ( γ T3) and δ ‐tocotrienol ( δ T3) on the human CRC cell lines HCC2998, HCT116, SW48 and Caco2. The cytotoxic effects were evaluated via cell viability assays, gene expression analysis and flow cytometry–based apoptosis detection. The results demonstrated that both γ T3 and δ T3 exhibited potent antiproliferative activities across all cell lines, with δ T3 generally showing lower IC 50 values. Gene expression analysis revealed cell line–specific responses, with HCT116 cells demonstrating significant upregulation of apoptosis‐related genes, particularly in response to γ T3 treatment. Flow cytometry confirmed the apoptosis‐inducing capabilities of both compounds, with effects intensifying from 24–48 h of treatment. The response of HCT116 cells was the most pronounced, especially in response to δ T3 treatment. Both γ T3 and δ T3, after 48 h of treatment, induced significant G 1 phase cell cycle arrest in HCC2998 cells, with δ T3 exhibiting a more pronounced suppression of S phase progression. These findings contribute to the growing evidence supporting the potential of T3 as a therapeutic agent for CRC, highlighting its ability to inhibit proliferation and induce apoptosis in multiple CRC cell lines. Further research is warranted to elucidate the precise mechanisms of action and evaluate the in vivo efficacy of these compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Food as Medicine Research Strength, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia, monash.edu.my.
ORCID-Profile: Ali Qusay Khalid, Saatheeyavaane Bhuvanendran, Kasthuri Bai Magalingam, Premdass Ramdas, Ammu Kutty Radhakrishnan
Förderung
- Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia
Zitieren
APA
Khalid, A. Q., Bhuvanendran, S., Magalingam, K. B., Ramdas, P., & Radhakrishnan, A. K. (2025). Inhibition of Proliferation and Induction of Apoptosis by Gamma‐ or Delta‐Tocotrienols in Human Colorectal Carcinoma Cells. BioMed Research International. https://doi.org/10.1155/bmri/4421336
Vancouver
Khalid AQ, Bhuvanendran S, Magalingam KB, Ramdas P, Radhakrishnan AK. Inhibition of Proliferation and Induction of Apoptosis by Gamma‐ or Delta‐Tocotrienols in Human Colorectal Carcinoma Cells. BioMed Research International. 2025. doi:10.1155/bmri/4421336
BibTeX
@article{Khalid2025,
author = {Khalid, Ali Qusay and Bhuvanendran, Saatheeyavaane and Magalingam, Kasthuri Bai and Ramdas, Premdass and Radhakrishnan, Ammu Kutty},
title = {Inhibition of Proliferation and Induction of Apoptosis by Gamma‐ or Delta‐Tocotrienols in Human Colorectal Carcinoma Cells},
journal = {BioMed Research International},
year = {2025},
doi = {10.1155/bmri/4421336}
}
EUVIMED